These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1672212)

  • 1. Prevention of side-effects of interferon.
    Visco G; Boumis E; Noto P; Comandini UV
    Lancet; 1991 Mar; 337(8743):741. PubMed ID: 1672212
    [No Abstract]   [Full Text] [Related]  

  • 2. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 3. Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.
    Chin K; Tabata C; Sataka N; Nagai S; Moriyasu F; Kuno K
    Chest; 1994 Mar; 105(3):939-41. PubMed ID: 8131569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of chronic active hepatitis C presenting heart failure during interferon alpha 2 alpha therapy].
    Shinagawa J; Inagaki Y; Suzuki M; Atsukawa K; Yonei Y; Tsukada N; Miyamoto K; Suzuki O; Kawamura Y; Kiryu Y
    Nihon Shokakibyo Gakkai Zasshi; 1995 May; 92(5):899-903. PubMed ID: 7783385
    [No Abstract]   [Full Text] [Related]  

  • 5. Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C.
    Fukumoto Y; Shigemitsu T; Kajii N; Omura R; Harada T; Okita K
    Intern Med; 1994 Oct; 33(10):637-40. PubMed ID: 7827383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune thrombocytopenia and interferon alfa.
    Kanfer EJ; McCarthy DM
    BMJ; 1988 Dec; 297(6663):1613. PubMed ID: 3147106
    [No Abstract]   [Full Text] [Related]  

  • 7. Induction of hyperthyroidism by interferon-alpha-2b.
    Schultz M; Müller R; von zur Mühlen A; Brabant G
    Lancet; 1989 Jun; 1(8652):1452. PubMed ID: 2567459
    [No Abstract]   [Full Text] [Related]  

  • 8. Alpha-interferon therapy and cutaneous vascular lesions.
    Dreno B; Huart A; Billaud E; Litoux P; Godefroy WY
    Ann Intern Med; 1989 Jul; 111(1):95-6. PubMed ID: 2786685
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of reaferon and antioxidants in children with chronic hepatitis].
    Frolov VM; Peresadin NA; Sidorova VS; Germanov VT; Pustovoĭ IuG
    Pediatriia; 1992; (4-6):60-2. PubMed ID: 1408577
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic hepatitis C with recombinant interferon alfa-2b.
    Piazza M; Orlando R; Tosone G; Tiseo D; Conte MC; Minervini F; Santoro G; Scordino F; Vitale D
    Gut; 1993; 34(2 Suppl):S128-9. PubMed ID: 8314479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment.
    Hirashima N; Mizokami M; Orito E; Yamauchi M; Narita M; Mizuno M; Tokuda Y; Nakano T; Kato M; Matsumoto T
    Intern Med; 1994 May; 33(5):300-2. PubMed ID: 7949634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocytosis in hairy cell leukaemia following therapy with interferon alpha.
    Steis RG; VanderMolen LA; Lawrence J; Sing G; Ruscetti F; Smith JW; Urba WJ; Clark J; Longo DL
    Br J Haematol; 1990 May; 75(1):133-5. PubMed ID: 2375913
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant fibroblast interferon and immune interferon for treating chronic hepatitis B virus infection: patients' tolerance and the effect on viral markers.
    Bissett J; Eisenberg M; Gregory P; Robinson WS; Merigan TC
    J Infect Dis; 1988 May; 157(5):1076-80. PubMed ID: 3129521
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of different regimens of interferon alfa-2b treatment in chronic hepatitis C.
    De Bac C; Grimaldi F; Clementi C; Duca F; Livoli D; Taliani G
    Gut; 1993; 34(2 Suppl):S135. PubMed ID: 8314480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.
    Métreau JM
    Gut; 1993; 34(2 Suppl):S112-3. PubMed ID: 8314474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-alpha interferon antibodies after alpha interferon treatment in patients with chronic viral hepatitis.
    Craxi A; Di Marco V; Volpes R; Palazzo U
    Hepatogastroenterology; 1988 Dec; 35(6):304-5. PubMed ID: 3063647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J; Caselmann W; Eder M; Pape GR
    Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chronic hepatitis delta--the course and approaches to therapy].
    Blokhina NP; Ketiladze ES; Kelli EI; Viazov SO
    Klin Med (Mosk); 1991 Mar; 69(3):85-8. PubMed ID: 2067348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation of multiple sclerosis after the administration of recombinant human interferon alfa.
    Larrey D; Marcellin P; Fréneaux E; Pessayre D; Benhamou JP
    JAMA; 1989 Apr; 261(14):2065. PubMed ID: 2494361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.